7. INTANGIBLE ASSETS
|3 Months Ended|
Mar. 31, 2018
|7. INTANGIBLE ASSETS||
Intangible assets at March 31, 2018 and December 31, 2017 consist of the following:
All of the Company’s intangible assets were acquired in the Biotest Transaction. Amortization expense related to these intangible assets for the three months ended March 31, 2018 was $0.2 million. Estimated aggregate future aggregate amortization expense for the next five years is expected to be as follows:
No definition available.
The entire disclosure for all or part of the information related to intangible assets.
Reference 1: http://www.xbrl.org/2003/role/presentationRef